OpenAlex
PricingAboutJobs
Log inGet started
Work

CH7233163 Overcomes Osimertinib-Resistant EGFR-Del19/T790M/C797S Mutation

HTML

Year: 2020
Type: article
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-20-0229
Authors: Kenji Kashima, Hiroki Kawauchi, Hiromi Tanimura, Yukako Tachibana, Takashi Chiba, Takuya Torizawa, Hiroshi Sakamoto
Institution: Chugai Pharmaceutical Co., Ltd. (Japan)
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: osimertinib resistance, EGFR, T790M mutation, C797S mutation, non-small cell lung cancer, ATP-competitive inhibitors, crystal structure, EGFR tyrosine kinase inhibitors
SDG: Good health and well-being

Open Access status: closed

Funders: Roche, Chugai Pharmaceutical
OpenAlex ID: W3087185067
FWCI: 8.945
Cites: 52
Cited by: 213
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security